CellWell record HH-156471
An Engineered Nano-Vesicle Adjuvant Platform (ENAP) for Cytokine Delivery Enables a Novel Antigen-Coordinated Vaccine Against Helicobacter pylori
Yinpan Shang; Xiran Zhang; Linwei Li; Xiaomin Yu; Lingbing Zeng; Yanli Cao; Ziwei Tao; Lu Shen; Shuaishuai Zhang; Chuangye Yang; Huizhen Tian; Ying Liang; Hanchen Liao; Xiaotian Huang; Qiong Liu
2026
In plain language
An engineered H. pylori-derived nano-vesicle platform enhanced mucosal IgA and Th1/Th17 immunity, substantially reducing bacterial colonization.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-156471
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.